Mitochondrial biology.
Mitochondrial-derived signals and mitochondria-targeting peptides. Findings depend on the exact molecule and disease context.
3 source-linked dossiers. Categories organize research context, not approved uses or promised benefits. Evidence labels refer to the sources discussed in each record.

Elamipretide
SS-31
Mitochondrial disease studies and Barth syndrome regulatory evidence.

Humanin
HN
Experimental cellular stress and neuroprotection models.

MOTS-c
Mitochondrial open reading frame of the 12S rRNA-c
Metabolic signaling and circulating peptide measurements.
Evidence labels describe the cited sources, not a complete systematic review, a safety rating or regulatory approval. This archive does not yet cover every peptide.
Read the background
Types of Peptides: Molecular Forms, Families and Evidence
Peptide types are easier to understand when chemistry, biological role and evidence are classified separately.
Peptide Clinical Trial Endpoints: Read Beyond the Headline
A peptide trial can measure a hormone concentration, a symptom score, a change in weight and an adverse event in the same study.
Preclinical vs Clinical Peptide Evidence: What Changes?
Research peptides can produce an interesting result in cultured cells long before there is a useful answer about people.